biopharmaceutical innovation – Talk Bio

Actionable Insights Powered by AI

Former FDA Deputy Dr. Namandjé N. Bumpus to Lead Charles River’s New Scientific Advisory Board

1 day ago talkbio0Tagged alternative testing, Animal Welfare, biopharmaceutical innovation, Charles River Laboratories, Drug Development, Namandjé Bumpus, NAMs, New Approach Methodologies, Scientific Advisory Board, United States Food and Drug Administration

Namandjé Bumpus; Charles River Laboratories; Scientific Advisory Board; FDA; New Approach Methodologies; NAMs; alternative testing; drug development; animal welfare; biopharmaceutical innovation

Takeda Expands De Novo Protein Research with Second AI-Driven Collaboration with Nabla Bio

3 days ago talkbio0Tagged AI drug discovery, antibody design, biopharmaceutical innovation, De Novo, JAM, Joint Atomic Model, multi-year collaboration, Nabla Bio, Takeda, therapeutic protein

Takeda; Nabla Bio; de novo protein design; AI drug discovery; Joint Atomic Model (JAM); multi-year collaboration; protein therapeutics; antibody design; biopharmaceutical innovation